Although little is known about the molecular mechanisms that regulate LCP1 transcription and translation, a variant in the promoter region of LCP1 causes a decreased risk for prostrate cancer (Chen et al. 2016) while other variants in LCP1 are proposed as biomarkers for colorectal cancer recurrence and eQTLs (Garge et al. 2010; Ning et al. 2014). This evidence concerns the gene LCP1 and colorectal cancer.